Core Viewpoint - A class action securities lawsuit has been filed against KBR, Inc. alleging securities fraud that affected shareholders between May 6, 2025, and June 19, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that KBR, Inc. made false statements regarding its partnership with HomeSafe, specifically that the U.S. Department of Defense had concerns about HomeSafe's ability to fulfill a global household goods contract, which KBR allegedly downplayed [3]. - The complaint asserts that KBR's statements about its business operations and future prospects were materially false and misleading, lacking a reasonable basis during the relevant time [3]. Group 2: Next Steps for Shareholders - Shareholders who suffered losses during the specified timeframe are encouraged to seek information on their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a history of securing significant recoveries for shareholders and has been ranked among the top securities litigation firms in the U.S. for seven consecutive years [5].

Core Viewpoint - The James Hardie Industries plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company misled investors about its sales performance during a period of inventory destocking [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled "Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc" and is filed in the Northern District of Illinois [1]. - Investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, have until December 23, 2025, to seek appointment as lead plaintiff [1][5]. - The lawsuit alleges that James Hardie executives made false statements about the strength of the North America Fiber Cement segment, despite evidence of inventory destocking [3]. Group 2: Financial Impact - On August 19, 2025, James Hardie disclosed a 12% decline in sales in the North America Fiber Cement segment due to customer destocking, which led to a stock price drop of over 34% [4]. - The lawsuit claims that the company engaged in practices resembling fraudulent channel stuffing, misleading investors about sustainable customer demand [3]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is representing investors in this class action lawsuit and is recognized as a leading law firm in securities fraud litigation [6]. - The firm has a strong track record, having recovered over $2.5 billion for investors in 2024 alone, and has been ranked 1 in securing monetary relief for investors [6].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for securities fraud, alleging significant stock drops due to potential violations of federal securities laws [1][3]. Company Overview - Stride, Inc. is an education technology company that provides an online platform to students across the U.S. [4]. Allegations - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students," ignored compliance requirements, and had a poor customer experience leading to higher withdrawal rates and lower conversion rates [4]. - Stride's statements about "increasing growth" and "strength in demand" are alleged to be misleading [4]. Stock Performance - On September 14, 2025, a report of the lawsuit caused Stride's stock to drop by $18.60, or over 11%, from $158.36 to $139.76 per share [5]. - Following Stride's admission of poor customer experience on October 28, 2025, the stock plummeted by $83.48, or more than 54%, from $153.53 to $70.05 per share [6]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [3]. - The lawsuit is captioned MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3]. Investor Actions - Investors are encouraged to seek additional information and may have legal options available [2][7].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for securities fraud following a significant stock drop due to alleged violations of federal securities laws [2][4]. Company Overview - Inspire Medical Systems, Inc. develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [5]. Allegations and Issues - The lawsuit claims that Inspire misled investors by assuring them that all necessary steps were taken for the launch of Inspire V, while in reality, the company failed to prepare clinicians and payors adequately, leading to delays in adoption [6][7]. - The company faced weak demand for Inspire V as many customers had excess inventory of older devices [7]. Stock Performance - On August 4, 2025, Inspire disclosed that the launch of Inspire V would take longer than expected, resulting in a reduction of its 2025 earnings per share guidance by over 80% [8]. - Following this announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 to $87.91 between August 4 and August 5, 2025 [9].

JHX CLASS NOTICE: BFA Law Alerts James Hardie Industries plc Investors of the Pending Securities Fraud Class Action and Upcoming December 23 DeadlineNovember 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud afte ...

MLTX CLASS NOTICE: BFA Law Alerts MoonLake Immunotherapeutics Investors of the Pending Securities Fraud Class Action and Upcoming December 15 DeadlineNovember 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the fe ...

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of California, titled Kim v. Synopsys, Inc., et al., No. 3:25-cv-09410 [3]. - Investors have until December 30, 2025, to request to be appointed to lead the case [3]. Group 2: Company Performance and Allegations - Synopsys provides design automation software and has seen its Design IP segment grow from 25% of revenue in 2022 to 31% in 2024 [4]. - The company previously claimed that customers relied on its IP to minimize integration risk and noted strength in Europe and South Korea [5]. - Allegations state that customers began requiring more customization for IP components, negatively impacting the economics of the Design IP business [5]. Group 3: Financial Impact - On September 9, 2025, Synopsys reported Q3 2025 results, revealing a 7.7% year-over-year decline in Design IP revenue to $425.9 million and a 43% year-over-year decline in net income to $242.5 million [6]. - Following the release of these results, Synopsys stock fell nearly 36%, from $604.37 per share to $387.78 per share [6].

KMX CLASS NOTICE: BFA Law Alerts CarMax, Inc. Investors of the Pending Securities Fraud Class Action and Upcoming January 2 DeadlineNovember 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resul ...

BYND SECURITIES NOTICE: BFA Law Alerts Beyond Meat, Inc. Investors of the Pending Securities Fraud Class Action Investigation and to Contact the Firm for DetailsNovember 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Beyond Meat, Inc. (NASDAQ: BYND) for potential violations of the federal securities laws. If you invested in Beyond Meat, you are ...

New York, New York--(Newsfile Corp. - November 18, 2025) - If you suffered a loss on your Stride, Inc. (NYSE: LRN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/stride-inc-lawsuit-submission-form-3?prid=177999&wire=5&utm_campaign=30or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE LAWSUIT: A cl ...